로딩 중…
지수 로딩 중…
Kymera Therapeutics, Inc.
KYMR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$90.43+0.59%
2026-06-18
Price Chart
Kymera Therapeutics, Inc.+94.72%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $7.44B |
| Revenue | $51M |
| Net Income | $-315M |
| Total Assets | $1.67B |
| Net Assets | $1.54B |
| Value | |
| P/B | 4.83x |
| P/S | 144.54x |
| FCF Yield | -3.28% |
| Profitability | |
| ROE | -20.46% |
| ROA | -18.88% |
| Op. Margin | -697.81% |
| Revenue Growth | 55.50% |
| Financial Health | |
| Debt Ratio | 8.40% |
| Total Debt | $80M |
| FCF | $-244M |
| Cash | $144M |
| Current Ratio | 10.81x |
| Performance | |
| 1Y Return | 94.72% |
| 1M Return | 15.73% |
| From 52W High | -12.20% |
| 1Y MDD | -27.74% |
| Trading | |
| Volume | 951,233 shares |
| Trading Value | $86M |
| Per Share | |
| EPS | $-3.69 |
| BPS | $18.72 |